- •
Systemic autoimmune diseases are becoming increasingly linked to accelerated risks of cardiovascular disease and events, and the idiopathic inflammatory myopathies (IIM) are not an exception to this growing pattern.
- •
Traditional risk factors for coronary artery disease, such as hypertension and hyperlipidemia, are associated with cardiovascular disease and events in patients with IIM.
- •
IIM patients with cardiac involvement are at increased risk for overall mortality when compared with IIM patients
The Heart in Inflammatory Myopathies
Section snippets
Key points
Methods
Articles were searched on pubmed.gov for the keywords of “Myositis” or “IIM” or “Myopathy” with the boolean operator AND followed by “Cardiovascular Disease” or “Cardiac” or “Cardiomyopathy” and appropriate articles were chosen. Only articles in English published after 2005 were chosen for inclusion if they were deemed to be appropriate for the current review as determined by the authors. In addition, Web searches for online textbooks in rheumatology and IIM were included besides the initial
Cardiomyopathies: Myocarditis
Cardiomyopathies can be defined as myocardial disorders in which the heart muscle is structurally and functionally abnormal in the absence of coronary artery disease (CAD), hypertension, valvular heart disease, and congenital heart disease.6 Cardiac magnetic resonance imaging (CMR) provides 3-dimensional data on cardiac anatomy, function, tissue characterization, coronary and microvascular perfusion, and valvular disease without ionizing radiation. Several case reports and case series have
Summary
Systemic autoimmune diseases are becoming increasingly linked to accelerated risks of cardiovascular disease and events. What is apparent from the above review is that the IIM are not an exception to this growing pattern. Although not always clinically apparent, there seems to be a large percentage of patients who have subclinical CV involvement. Many of the traditional risk factors for CAD, such as hypertension and hyperlipidemia, are associated with developing cardiac involvement in patients
References (30)
- et al.
Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in large series of patients with polymyositis and dermatomyositis
Clinics
(2013) - et al.
Contrast-enhanced CMR imaging reveals myocardial involvement in idiopathic inflammatory myopathy without cardiac manifestations
JACC Cardiovasc Imaging
(2011) - et al.
Cardiac involvement in juvenile overlap-myositis detected by cardiac magnetic resonance imaging
Int J Cardiol
(2011) - et al.
Myocarditis during acute inflammatory myopathies-evaluations using clinical criteria and cardiac magnetic resonance imaging
Int J Cardiol
(2013) - et al.
Myocardial dysfunction in polymyositis
Can J Cardiol
(2006) - et al.
Cardiovascular disease in autoimmune rheumatic diseases
Autoimmun Rev
(2013) - et al.
Clinical status and cardiovascular risk profile of adults with a history of juvenile dermatomyosits
J Pediatr
(2011) - et al.
Clinical cardiac involvement in idiopathic inflammatory myopathies: a systemic review
Int J Cardiol
(2011) - et al.
Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial
Lancet
(2004) - et al.
Inflammatory diseases of muscle and other myopathies
(2012)
Diagnosis and management of inflammatory muscle disease
J Musculoskelet Med
The heart in dermatomyositis and polymyositis
Rheumatology
Role of Cardiac MRI in the assessment of nonischemic cardiomyopahties
Methodist Debakey Cardiovasc J
Cardiac dysfunction in juvenile dermatomyositis: a case-control study
Ann Rheum Dis
Cited by (28)
Management of Connective Tissue Disease-Associated Interstitial Lung Disease
2021, Clinics in Chest MedicineCitation Excerpt :Extrapolating from IPF, patients with CTD-ILD angina or moderate to severe coronary calcifications on HRCT should be referred for cardiologic evaluation. Cardiovascular disease as a consequence of CTD is most frequent in SSc and in PM/DM, in which cardiac disease is the third most frequent cause of death after lung disease and malignancy.121 Subclinical disease is more frequent than clinically evident cardiac disease.
Third degree atrio-ventricular blockade during a myocarditis occurring under anti-PD1 : Case report and literature review
2020, Revue de Medecine InterneDilated Cardiomyopathy and Cardioskeletal Involvement
2017, Cardioskeletal Myopathies in Children and Young AdultsElectrocardiographic changes in dermatomyositis and polymyositis
2016, Revista Brasileira de ReumatologiaCitation Excerpt :So far, there are few studies evaluating electrocardiographic changes in patients with DM and PM; and, when present, these are limited to a small number of cases and/or in the absence of a control group,7,9,10,12,13 differently of the present study. ECG changes in idiopathic inflammatory myopathies occur in 33–72%.3–5,7–13 Our data show that LVH was significantly present in patients with DM and PM compared to the control group.
Cardiovascular events in adult polymyositis and dermatomyositis: A meta-analysis of observational studies
2022, Rheumatology (United Kingdom)